INIFY Laboratories AB (OSL:INIFY) EV-to-FCF : (As of Apr. 20, 2025)

INIFY Laboratories AB EV-to-FCF Chart

INIFY Laboratories AB Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EV-to-FCF	Get a 7-Day Free Trial							-	-	-	-	-

Competitive Comparison of INIFY Laboratories AB's EV-to-FCF

For the Diagnostics & Research subindustry, INIFY Laboratories AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

INIFY Laboratories AB's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, INIFY Laboratories AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where INIFY Laboratories AB's EV-to-FCF falls into.

INIFY Laboratories AB EV-to-FCF Calculation

INIFY Laboratories AB's EV-to-FCF for today is calculated as:

INIFY Laboratories AB's current Enterprise Value is kr519.96 Mil.
INIFY Laboratories AB's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

INIFY Laboratories AB  (OSL:INIFY) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

INIFY Laboratories AB's PE Ratio (TTM) for today is calculated as:

INIFY Laboratories AB's share price for today is kr6.90.
INIFY Laboratories AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.154.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

INIFY Laboratories AB EV-to-FCF Related Terms

Thank you for viewing the detailed overview of INIFY Laboratories AB's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

INIFY Laboratories AB Business Description